Gene Delivery

Latest content

John Chappell, Scientific Support Manager at Gyros Protein Technologies

Editorial ArticleDrug Discovery & Development

Anti-AAV antibody testing emerges as key to gene therapy

Advance gene therapy precision by reliably testing pre-existing AAV immunogenicity

1 Jul 2025

Product NewsDrug discovery > Basic Research

Clearing the Way with Customized Viral Vectors

27 Jun 2017

Editorial Articles

John Chappell, Scientific Support Manager at Gyros Protein Technologies

Editorial Article

Anti-AAV antibody testing emerges as key to gene therapy

1 Jul 2025

Resources

Application Note

Multiplexed delivery of biomolecules for next-gen cell engineering

14 Oct 2025

Gene Delivery